injected APS into HCC BALB/c mice (100, 200, and 400 mg/kg per day for 12 consecutive days) and observed increased CD8+ T cell count, decreased PD-L1 levels, and reduced tumor size, weight, and volume. The gene discussed is CD274; the disease is neoplasm.